Immunomodulatory Effects of Adipose Stromal Vascular Fraction Cells Promote Alternative Activation Macrophages to Repair Tissue Damage

Stem Cells

Volumn 35, Issue 10, 2017, Pages 2198-2207

  Bowles, Annie C ^a,b   Wise, Rachel M ^a   Gerstein, Brittany Y ^b   Thomas, Robert C ^b   Ogelman, Roberto ^b   Febbo, Isabella ^b   Bunnell, Bruce A ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tulane University   (United States)

Author keywords

Adipose stem cells; Alternative activation macrophages; Immunomodulation; Neurodegeneration; Stem cell therapy; Stromal cells; Th1 Th2

Indexed keywords

INTERLEUKIN 10; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL INFILTRATION; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOMODULATION; LYMPHOID CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SPLEEN; TH1 CELL; TH17 CELL; TISSUE REPAIR; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; DISEASE MODEL; IMMUNOLOGY; METABOLISM; PATHOLOGY; STROMA CELL;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; DISEASE MODELS, ANIMAL; IMMUNOMODULATION; MACROPHAGES; MICE; STROMAL CELLS;

EID: 85027676935     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2689     Document Type: Article

References (36)

1. Amor S, Peferoen LA, Vogel DY et al. Inflammation in neurodegenerative diseases. Immunology 2010;129:154–169.
2. Gandhi R, Laroni A, Weiner HL. Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol 2010;221:7–14.
3. Wu GF, Alvarez E. The immunopathophysiology of multiple sclerosis. Neurol Clin 2011;29:257–278.
4. Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006;129:1953–1971.
5. Weiner HL. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch Neurol 2004;61:1613–1615.
6. Fletcher JM, Lalor SJ, Sweeney CM et al. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 2010;162:1–11.
7. Lutz SE, Lengfeld J, Agalliu D. Stem cell-based therapies for multiple sclerosis: Recent advances in animal models and human clinical trials. Regen Med 2014;9:129–132.
8. Lassmann H, Bruck W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: Implications for diagnosis and therapy. Trends Mol Med 2001;7:115–121.
9. Constantinescu CS, Farooqi N, O'Brien K et al. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 2011;164:1079–1106.
10. Strong AL, Bowles AC, Wise RM et al. Human adipose stromal/stem cells from obese donors show reduced efficacy in halting disease progression in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Stem Cells 2016;34:614–626.
11. Bowles AC, Strong AL, Wise RM et al. Adipose stromal vascular fraction-mediated improvements at late-stage disease in a murine model of multiple sclerosis. Stem Cells 2016;35:532–544.
12. Scruggs BA, Semon JA, Zhang X et al. Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model. Stem Cells Trans Med 2013;2:797–807.
13. Semon JA, Maness C, Zhang X et al. Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis. Stem Cell Res Ther 2014;5:2.
14. Cua DJ, Sherlock J, Chen Y et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421:744–748.
15. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006;116:1218–1222.
16. Leonard JP, Waldburger KE, Goldman SJ. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 1995;181:381–386.
17. Darlington PJ, Touil T, Doucet JS et al. Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation. Ann Neurol 2013;73:341–354.
18. Jager A, Dardalhon V, Sobel RA et al. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 2009;183:7169–7177.
19. Zhang GX, Gran B, Yu S et al. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J Immunol 2003;170:2153–2160.
20. Ding L, Gu H, Gao X et al. Aurora kinase a regulates m1 macrophage polarization and plays a role in experimental autoimmune encephalomyelitis. Inflammation 2015;38:800–811.
21. Jiang Z, Jiang JX, Zhang GX. Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis. Immunol Lett 2014;160:17–22.
22. Hucke S, Eschborn M, Liebmann M et al. Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity. J Autoimmun 2016;67:90–101.
23. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: Time for reassessment. F1000Prime Rep 2014;6:13.
24. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23–35.
25. Mikita J et al. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 2011;17:2–15.
26. Redente EF, Higgins DM, Dwyer-Nield LD et al. Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. J Leukoc Biol 2010;88:159–168.
27. Park-Min KH, Antoniv TT, Ivashkiv LB. Regulation of macrophage phenotype by long-term exposure to IL-10. Immunobiology 2005;210:77–86.
28. Liu C, Li Y, Yu J et al. Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil. PLoS One 2013;8:e54841.
29. Oishi S, Takano R, Tamura S et al. M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T-cell proliferation. Immunology 2016;149:320–328.
30. Chen C, Li YH, Zhang Q et al. Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis. Acta Pharmacol Sin 2014;35:1428–1438.
31. Saraiva M, O'garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010;10:170–181.
32. Orihuela R, McPherson CA, Harry GJ. Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 2016;173:649–665.
33. Deshpande P, King IL, Segal BM. Cutting edge: CNS CD11c+ cells from mice with encephalomyelitis polarize Th17 cells and support CD25+CD4+ T cell-mediated immunosuppression, suggesting dual roles in the disease process. J Immunol 2007;178:6695–6699.
34. Murphy AC, Lalor SJ, Lynch MA et al. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 2010;24:641–651.
35. Zhu M, Zhou Z, Chen Y et al. Supplementation of fat grafts with adipose-derived regenerative cells improves long-term graft retention. Ann Plast Surg 2010;64:222–228.
36. Yoshimura K, Sato K, Aoi N et al. Cell-assisted lipotransfer for facial lipoatrophy: Efficacy of clinical use of adipose-derived stem cells. Dermatol Surg 2008;34:1178–1185.